This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nu Skin Enterprises (NUS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Estee Lauder Companies (EL) Up 61% in a Year: Here's How
by Zacks Equity Research
The Estee Lauder Companies (EL) has a strong online business. The company's Skin Care portfolio is performing well.
Coty's (COTY) Innovation Solid, Launches Touch-Less Fragrance Tester
by Zacks Equity Research
Coty (COTY) will introduce a digitally-enabled touch-less fragrance tester at beauty retailers in the next 12 months. Management expects to improve in-store sales via the launch.
Nu Skin (NUS) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Nu Skin Enterprises (NUS) has been struggling lately, but the selling pressure may be coming to an end soon
Helen of Troy's (HELE) Q1 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter fiscal 2022 results reflect growth in earnings and net sales on strength in all segments.
Buy These 5 Low Leverage Stocks to Keep Debt Risks Away
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not overburdened with debt as a debt-free stock is almost impossible to find. You may buy NUS, SON, NX, WRI and TD.
Inter Parfums (IPAR)-Salvatore Ferragamo Deal to Fuel Growth
by Zacks Equity Research
Inter Parfums (IPAR) inks a deal with Salvatore Ferragamo to fuel growth across the fragrance business.
New Strong Buy Stocks for July 2nd
by Zacks Equity Research
PIPR, TA, NUS, BKR, and LYB have been added to the Zacks Rank #1 (Strong Buy) List on July 2, 2021.
Coty's (COTY) Kylie Cosmetics Relaunch to Fortify Business
by Zacks Equity Research
Coty (COTY) relaunches Kylie Cosmetics, now formulated using clean and vegan ingredients with a revamped packaging. The launch will be available on direct-to-consumer site and at select retailers.
7 Low Price-to-Sales Stocks for Value-Focused Investors
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like NUS, FL, SIG, MET, MT, VSH and SMP are promising picks.
Nu Skin (NUS) Looks Promising: Stock Up More Than 45% in a Year
by Zacks Equity Research
Nu Skin (NUS) is focused on empowering sales leaders and customers through product launches and engaging technology platforms, among other initiatives.
Solid Skin Care & Online Sales Aid The Estee Lauder Companies (EL)
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. Also, the company's online operations look impressive.
4 Cosmetic Stocks to Watch as Consumers Get Ready to Head Out
by Vrishali Bagree
Focus on strengthening brands through innovation and product launches, along with increased use of cosmetics with people gradually stepping out, bodes well for The Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).
Inter Parfums (IPAR) Looks Solid, Gains More Than 35% in 6 Months
by Zacks Equity Research
Inter Parfums (IPAR) has been gaining on constant product launches and strategic partnerships. The company's 2021 guidance looks encouraging.
Helen of Troy (HELE) Spins Off Market Personal Care Business
by Zacks Equity Research
Helen of Troy (HELE) divests mass market Personal Care business (excluding the Latin America and Caribbean regions) to HRB Brands LLC as part of its strategy to focus on Leadership Brands.
Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums
by Zacks Equity Research
Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums
4 Cosmetics Stocks Stealing Attention Despite Industry Woes
by Vrishali Bagree
The Zacks Cosmetics industry is battling COVID-19 hurdles like disrupted travel retail and low store traffic. However, high demand for personal care products and focus on innovation bodes well for Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).
Nu Skin (NUS) Up 3.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Coty (COTY) Poised on Strength in Core Priorities & Partnerships
by Zacks Equity Research
Coty (COTY) makes several strategic partnerships to enhance its brand portfolio. Also, it is on track with six priorities aimed at sustainable growth.
Nu Skin (NUS) Looks Buoyant on Product Launches & Online Sales
by Zacks Equity Research
Nu Skin (NUS) is benefiting from its focus on innovation and efforts to strengthen sales leader as well as expand customer base.
The Estee Lauder Companies (EL) Looks Poised on Online Sales
by Zacks Equity Research
The Estee Lauder Companies (EL) is benefiting from growing online sales. Also, the company's Skin Care portfolio looks impressive.
The Estee Lauder Companies (EL) Ups DECIEM Stake, Boosts Skincare
by Zacks Equity Research
The Estee Lauder Companies (EL) now has nearly 76% ownership in DECIEM compared with 29% earlier. This is likely to fuel its skincare business.
Inter Parfums (IPAR) Q1 Earnings Top Estimates, Increase Y/Y
by Zacks Equity Research
Inter Parfums' (IPAR) first-quarter 2021 results reflect strong top and bottom lines. Solid performances in regions where lockdowns have been eased benefit results.
Nu Skin (NUS) Stock Gains on Q1 Earnings Beat & Raised View
by Zacks Equity Research
Nu Skin's (NUS) first-quarter 2021 earnings and revenues increase year over year on growth in sales leaders and customer base. Also, management raises 2021 view.
Nu Skin Enterprises (NUS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 26.39% and 6.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?